Home › Pancreatic Cancer › Washington › Tacoma
Pancreatic Cancer clinical trials in Tacoma, WA
6 studies for Pancreatic Cancer are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Madigan Army Medical Center, Tacoma
Pancreatic Cancer Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- MultiCare Cancer Institute - Tacoma General Hospital, Tacoma
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
- Investigative Site US081, Olympia · 26 mi away
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecruitingPhase 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RecruitingPhase 2/3
- MultiCare Regional Cancer Center - Tacoma, Tacoma
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer18 studies
- Ulcerative Colitis15 studies
- Multiple Myeloma13 studies
- Prostate Cancer11 studies
- Crohn's Disease11 studies
- Colorectal Cancer9 studies
- Metastatic Cancer9 studies
- Melanoma7 studies
- Ovarian Cancer7 studies
- Stomach Cancer6 studies
- Esophageal Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.